TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
100,987
|
101,319
|
86,616 |
| Financial expenses |
21
|
1
|
13 |
| Earnings before taxes |
9,261
|
7,335
|
8,180 |
| EBITDA |
10,866
|
8,818
|
9,043 |
| Total assets |
49,463
|
42,042
|
35,537 |
| Current assets |
45,602
|
36,629
|
30,377 |
| Current liabilities |
29,441
|
28,901
|
28,164 |
| Equity capital |
20,022
|
13,141
|
7,373 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
21
|
22
|
19 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.5%
|
31.3%
|
20.7% |
| Turnover per employee |
4,809
|
4,605
|
4,559 |
| Profit as a percentage of turnover |
9.2%
|
7.2%
|
9.4% |
| Return on assets (ROA) |
18.8%
|
17.4%
|
23.1% |
| Current ratio |
154.9%
|
126.7%
|
107.9% |
| Return on equity (ROE) |
46.3%
|
55.8%
|
110.9% |
| Change turnover |
3,019
|
14,258
|
16,609 |
| Change turnover % |
3%
|
16%
|
24% |
| Chg. No. of employees |
-1
|
3
|
1 |
| Chg. No. of employees % |
-5%
|
16%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.